Swain, Mark G <br/><br/>
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.  [electronic resource] 

 -  Gastroenterology  Nov 2010 
 - 1593-601 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2010.07.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Carriers<br/>Drug Therapy, Combination<br/>Follow-Up Studies<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Polyethylene Glycols--administration & dosage<br/>RNA, Viral--analysis<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load--drug effects